Diabetes Clinical Trials in San Diego

Showing 181-200 of 515 trials

Insulin Degludec Titration Using Mobile Insulin Dosing System

NCT03091712

This is an open label randomized, controlled, parallel intervention study. Group 1 will receive usual care for insulin degludec titration using the STEP WISE degludec titration algorithm Group 2 will receive Glooko mobile insulin dosing system, using the STEP WISE degludec titration algorithm.An estimated n= 240 subjects with type 2 diabetes will be enrolled in order to obtain approximately 200 evaluable subjects who will complete the 16 week study.

Type 2 Diabetes Mellitus

Glooko240 participantsStarted May 2017

San Diego, California, United States

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes

NCT03136484

This trial is conducted in Africa, Asia, Europe, North and South America. The aim of the trial is to compare the effect of once-weekly (OW) dosing of subcutaneous semaglutide (1.0 mg) versus once-daily dosing of oral canagliflozin (300 mg) on glycaemic control in subjects with type 2 diabetes (T2D) on a background treatment of metformin

DiabetesDiabetes Mellitus, Type 2

Novo Nordisk A/S788 participantsStarted Mar 2017

Anaheim, California, United States • La Mesa, California, United States • Los Angeles, California, United States +116 more locations

Insulin Degludec Titration Using Mobile Insulin Dosing System

Efficacy and Safety of Semaglutide Versus Canagliflozin as add-on to Metformin in Subjects With Type 2 Diabetes

Diabetes Trials in Other Cities

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy

G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes

Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With Albuminuria

Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy

Examination of the Anti-inflammatory and Insulin Sensitizing Properties of Doxycycline in Humans

An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 Diabetes

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin

4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes

A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

Patient and Provider Assessment of Lipid Management Registry

Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes

Rituximab in New Onset Type 1 Diabetes

Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes

Dose-ranging Study in Patients With Type 1 Diabetes Mellitus

Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus

Imatinib Treatment in Recent Onset Type 1 Diabetes Mellitus

Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C

An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes

Other Conditions in San Diego